{"database": "openregs", "table": "dockets", "rows": [["FDA-2025-P-3849", "FDA", "Requests that the FDA determine whether OZEMPIC (semaglutide) Injection, 2 mg/1.5 mL (1.34 mg/mL) was withdrawn for safety or effectiveness reasons.", "Nonrulemaking", "2026-04-30T16:25:46Z", "0b000064b8f8b096"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2025-P-3849"], "units": {}, "query_ms": 0.6639808416366577, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}